Physician profile
Tiny K Varghese
NPI 1336463371
$1,689.78
in general payments reported to CMS, 2019-2025
10 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.88 · 2020: $47.70 · 2021: $264 · 2022: $140 · 2023: $459 · 2024: $467 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $699.86 | 2020-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $241.69 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $186.87 | 2023-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $164.34 | 2023-2024 | Camzyos, Eliquis |
| Pfizer INC. | $121.20 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.64 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $74.66 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $61.58 | 2021-2024 | Andexxa |
| Bayer Healthcare Pharmaceuticals INC. | $21.98 | 2025 | |
| Philips North America LLC | $18.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiny Varghese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.